Among the 78 cases where we could examine the index tumor location, 33% were centered anterior to the urethra, which is somewhat higher than the ~15% rate of anterior-dominant tumors reported in other radical prostatectomy cohorts [45], and perhaps in line with the lower rate of ERG expression among the G84E carriers. The gene discussed is ERG; the disease is neoplasm.